Related Experiment Video
Updated: Jul 1, 2025

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Male Lrp5A214V mice maintain high bone mass during dietary calcium restriction by altering the vitamin D endocrine
Serra Ucer Ozgurel1, Perla C Reyes Fernandez2, Krittikan Chanpaisaeng3,4
1Department of Nutritional Sciences, University of Texas, Austin, TX 78723, United States.
Abstract:
Environmental factors and genetic variation individually impact bone. However, it is not clear how these factors interact to influence peak bone mass accrual. Here we tested whether genetically programmed high bone formation driven by missense mutations in the Lrp5 gene (Lrp5A214V) altered the sensitivity of mice to an environment of inadequate dietary calcium (Ca) intake. Weanling male Lrp5A214V mice and wildtype littermates (control) were fed AIN-93G diets with 0.125%, 0.25%, 0.5% (reference, basal), or 1% Ca from weaning until 12 weeks of age (ie, during bone growth). Urinary Ca, serum Ca, Ca regulatory hormones (PTH, 1,25 dihydroxyvitamin D3 (1,25(OH)2D3)), bone parameters (μCT, ash), and renal/intestinal gene expression were analyzed. As expected, low dietary Ca intake negatively impacted bones and Lrp5A214V mice had higher bone mass and ash content. Although bones of Lrp5A214V mice have more matrix to mineralize, their bones were not more susceptible to low dietary Ca intake. In control mice, low dietary Ca intake exerted expected effects on serum Ca (decreased), PTH (increased), and 1,25(OH)2D3 (increased) as well as their downstream actions (ie, reducing urinary Ca, increasing markers of intestinal Ca absorption). In contrast, Lrp5A214V mice had elevated serum Ca with a normal PTH response but a blunted 1,25(OH)2D3 response to low dietary Ca that was reflected in the renal 1,25(OH)2D3 producing/degrading enzymes, Cyp27b1 and Cyp24a1. Despite elevated serum Ca in Lrp5A214V mice, urinary Ca was not elevated. Despite an abnormal serum 1,25(OH)2D3 response to low dietary Ca, intestinal markers of Ca absorption (Trpv6, S100g mRNA) were elevated in Lrp5A214V mice and responded to low Ca intake. Collectively, our data indicate that the Lrp5A214V mutation induces changes in Ca homeostasis that permit mice to retain more Ca and support their high bone mass phenotype.
Insights
Mice with a specific Lrp5 gene mutation maintain high bone mass despite low dietary calcium intake by altering calcium homeostasis and absorption. This genetic factor influences bone accrual and calcium regulation.
Area of Science:
- Bone Biology and Genetics
- Mineral Metabolism
- Nutritional Science
Background:
- Peak bone mass accrual is influenced by both environmental factors and genetic variations.
- The interaction between genetics and diet in bone development is not fully understood.
- The Lrp5 gene plays a critical role in bone formation and regulation.
Purpose of the Study:
- To investigate the interaction between genetic predisposition for high bone formation (Lrp5A214V mutation) and inadequate dietary calcium intake.
- To determine if Lrp5A214V mice exhibit altered sensitivity to low calcium environments during bone growth.
- To elucidate the mechanisms of calcium homeostasis and bone accrual under combined genetic and dietary challenges.
Main Methods:
- Utilized Lrp5A214V mutant mice and wildtype littermates, fed varying dietary calcium levels (0.125% to 1%) from weaning to 12 weeks.
- Analyzed urinary and serum calcium, calcium-regulatory hormones (PTH, 1,25(OH)2D3), bone parameters (micro-CT, ash content).
- Assessed renal and intestinal gene expression related to calcium transport and metabolism.
Main Results:
- Lrp5A214V mice exhibited higher bone mass and ash content, irrespective of dietary calcium.
- Despite low dietary calcium, Lrp5A214V mice maintained elevated serum calcium and increased intestinal calcium absorption markers.
- These mice showed a blunted 1,25-dihydroxyvitamin D3 response but effectively retained calcium, supporting their high bone mass phenotype.
Conclusions:
- The Lrp5A214V mutation confers resistance to the negative effects of low dietary calcium on bone accrual.
- Genetic modulation of Lrp5 influences calcium homeostasis, promoting calcium retention and high bone mass.
- This study highlights the complex interplay between genetic factors and nutrition in determining skeletal health.
More Related Videos
08:42Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
04:24Proper Positioning and Restraint of a Rat Hind Limb for Focused High Resolution Imaging of Bone Micro-architecture Using In Vivo Micro-computed Tomography
Published on: November 22, 2017
Related Concept Videos
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Skeleton and Calcium Homeostasis
Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Osteoclasts in Bone Remodeling